Evidence map›Paper›PMID 26096434›Full record

ArticleMolecules (Basel, Switzerland)2015

Selected Compounds Structurally Related to Acyclic Sesquiterpenoids and Their Antibacterial and Cytotoxic Activity.

Radosław Bonikowski, Paulina Świtakowska, Monika Sienkiewicz, Małgorzata Zakłos-Szyda

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Understanding the Antilymphoma Activity ofMolecules (Basel, Switzerland) · 2022
    Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Radosław BonikowskiInstitute of General Food Chemistry, Łódź University of Technology, Stefanowskiego St. 4/10, 90-924 Łódź, Poland. radoslaw.bonikowski@p.lodz.pl.
Paulina ŚwitakowskaInstitute of General Food Chemistry, Łódź University of Technology, Stefanowskiego St. 4/10, 90-924 Łódź, Poland. paulina@toya.net.pl.
Monika SienkiewiczEnvironmental Biology Department, Medical University of Łódź, Żeligowskiego St. 7/9, 90-752 Łódź, Poland. monika.sienkiewicz@umed.lodz.pl.
Małgorzata Zakłos-SzydaInstitute of Technical Biochemistry, Łódź University of Technology, Stefanowskiego St. 4/10, 90-924 Łódź, Poland. malgorzata.zaklos-szyda@p.lodz.pl.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

By implementing a common and industrially used method, 30 compounds which are structurally related to geranyl acetone, nerolidol, farnesal, farnesol and farnesyl acetate were obtained. Their antimicrobial activity against Staphylococcus aureus, Enterococcus faecalis, Enterococcus faecium, Escherichia coli, Klebsiella pneumoniae and Acinetobacter baumannii bacteria was investigated. Pharmacophore models were proposed based on the obtained results and 3D QSAR modelling. Cytotoxic effects against mainly human immortalised and normal cell lines of different origin (malignant melanoma MeWo, colorectal adenocarcinoma HT29, promyelocytic leukemia HL60, gingival fibroblasts HFIG, skin keratinocytes HaCaT and rat small intestine epithelium IEC6) were examined. The odour descriptions of newly synthesised compounds are given.

Indexed as

Anti-Bacterial AgentsCell SurvivalHL-60 CellsHumansInhibitory Concentration 50Microbial Sensitivity TestsModels, MolecularMolecular ConformationMolecular StructureSesterterpenesAnti-Bacterial AgentsSesterterpenesantimicrobial activitycytotoxicityfarnesolfarnesyl acetategeranyl acetonenerolidolstructurally related compoundterpenoids

Identifiers

PMID26096434
PMCPMC6272674

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.